Europe Animal Antimicrobial And Antibiotics Market Size & Outlook
Europe animal antimicrobial and antibiotics market, 2018-2030 (US$M)
Related Markets
Europe animal antimicrobial and antibiotics market highlights
- The Europe animal antimicrobial and antibiotics market generated a revenue of USD 230.8 million in 2022.
- The market is expected to grow at a CAGR of 3.4% from 2023 to 2030.
- In terms of segment, antibiotics was the largest revenue generating type in 2022.
- Antimicrobial is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2023 to 2030.
Europe data book summary
| Market revenue in 2022 | USD 230.8 million |
| Market revenue in 2030 | USD 300.7 million |
| Growth rate | 3.4% (CAGR from 2022 to 2030) |
| Largest segment | Antibiotics |
| Fastest growing segment | Antimicrobial |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antimicrobial, Antibiotics |
| Key market players worldwide | Boehringer Ingelheim, CEVA Inc, Elanco Animal Health Inc, Neogen Corp, Phibro Animal Health Corp Class A, Vetoquinol SA, Virbac SA, Zoetis Inc Class A |
Other key industry trends
- In terms of revenue, Europe region accounted for 34.0% of the global animal antimicrobial and antibiotics market in 2022.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 270.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Animal Antimicrobial And Antibiotics Market Scope
Animal Antimicrobial And Antibiotics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe animal antimicrobial and antibiotics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to animal antimicrobial and antibiotics market will help companies and investors design strategic landscapes.
Antibiotics was the largest segment with a revenue share of 56.93% in 2022. Horizon Databook has segmented the Europe animal antimicrobial and antibiotics market based on antimicrobial, antibiotics covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is home to some of the world's most advanced animal husbandry practices, which include advanced breeding techniques, sophisticated housing systems, and advanced feeding practices. These practices lead to healthier animals that are less susceptible to disease, reducing the need for antibiotics and other antimicrobials.
The European Union has implemented several measures aimed at reducing the use of antibiotics in livestock, including a limitation on the use of antibiotics as growth promoters and the introduction of national action plans to reduce the use of antibiotics in animals. As a result of these measures, the market for animal antibiotics in Europe has declined in recent years.
Reasons to subscribe to Europe animal antimicrobial and antibiotics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe animal antimicrobial and antibiotics market databook
-
Our clientele includes a mix of animal antimicrobial and antibiotics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe animal antimicrobial and antibiotics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe animal antimicrobial and antibiotics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe animal antimicrobial and antibiotics market size, by country, 2018-2030 (US$M)
Europe Animal Antimicrobial And Antibiotics Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
